Estimated Glomerular Filtration Rate Is a Poor Predictor of Concentration for a Broad Range of Uremic Toxins
- 1 June 2011
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 6 (6), 1266-1273
- https://doi.org/10.2215/cjn.09981110
Abstract
Summary: Background and objectives: The degree of chronic kidney disease (CKD) is currently expressed in terms of GFR, which can be determined directly or estimated according to different formulas on the basis of serum creatinine and/or cystatin C measurements (estimated GFR [eGFR]). The purpose of this study was to investigate whether eGFR values are representative for uremic toxin concentrations in patients with different degrees of CKD. Design, setting, participants, & measurements: Associations between eGFR based on serum cystatin C and different uremic solutes (mol wt range 113 to 240 D; determined by colorimetry, HPLC, or ELISA) were evaluated in 95 CKD patients not on dialysis (CKD stage 2 to 5). The same analysis was also applied for six other eGFR formulas. Results: There was a substantial disparity in fits among solutes. In linear regression, explained variance of eGFR was extremely low for most solutes, with eGFR > 0.4 only for creatinine. The other eGFR formulations gave comparably disappointing results with regard to their association to uremic solutes. Relative similarity in R 2 values per solute for the different eGFR values and the strong disparity in values between solutes suggest that the differences in R 2 are mainly due to discrepancies in solute handling apart from GFR. Conclusions: eGFR is poorly associated with concentrations of all studied uremic toxins in patients with different degrees of CKD, correlates differently with each individual solute, and can thus not be considered representative for evaluating the accumulation of solutes in the course of CKD.Keywords
This publication has 45 references indexed in Scilit:
- A Randomized, Controlled Trial of Early versus Late Initiation of DialysisNew England Journal of Medicine, 2010
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Free p-cresol is associated with cardiovascular disease in hemodialysis patientsKidney International, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- ADMA Levels Correlate with Proteinuria, Secondary Amyloidosis, and Endothelial DysfunctionJournal of the American Society of Nephrology, 2008
- Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyDiabetes Care, 2006
- The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repairKidney International, 2004
- Extraction of protein bound ligands from azotemic sera: Comparison of 12 deproteinization methodsKidney International, 1992
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.Journal of Clinical Investigation, 1975